They tend to occur more frequently in the proximal right colon. MSI-H tumors tend to appear poorly differentiated, often accompanied by a mucinous or medullary architecture and a prominent peritumoral lymphocytic infiltrate (21-23). Interestingly, tumors with MSI-H tend to show an increased number of lymph nodes (25) as compared to tumors that are MSS. They also demonstrate a more www.selleckchem.com/products/Tipifarnib(R115777).html favorable Inhibitors,research,lifescience,medical clinical course. Changing trends Trends are changing with regard to lymph nodes in colorectal cancer staging. Multiple papers reported significantly increased

overall survival and disease-free survival as the number of lymph nodes retrieved increased regardless of whether the lymph nodes were positive or negative for metastatic disease (5-11). This increase in survival was initially attributed to more accurate staging; that is, increased numbers of retrieved nodes more accurately reflected the true node status of the patient. Thus, less under-staging results in appropriately utilized chemotherapy. Increased numbers of harvested nodes increased the rate of node positivity, Inhibitors,research,lifescience,medical but with diminishing returns. Some studies showed a link between higher lymph node counts and node positivity. However, sampling beyond a certain number failed to significantly increase the sensitivity of diagnosing metastatic disease

(12). More recent data also support this, showing that there appears to Inhibitors,research,lifescience,medical be an upper limit where more lymph nodes retrieved do not improve staging, and thus logically, should not affect survival. For instance, Baxter et al. recently demonstrated

Inhibitors,research,lifescience,medical that in patients with pT3 colon carcinoma those with 7 nodes examined were equally as better likely as those with 30 nodes examined to be node positive (13). In addition, they Inhibitors,research,lifescience,medical discovered that patients with very high lymph node counts (greater than 18) were actually less likely to have positive nodes than those with intermediate counts (12-17 lymph nodes). Ervine et al. in an exhaustive study of all lymph nodes in 391 consecutive cases, found only 1% in which upstaging would have been appropriate. The team further suggested that even these would likely have been upstaged without the additional node sampling due to other tumor findings (26). This suggestion has been confirmed GSK-3 in additional reports which (11) imply that up-staging is not the mechanism responsible for increased survival. There are likely other confounding factors associated with survival and the number of nodes retrieved. These may include tumor biological factors, tumor-host interaction and lymph nodes as a marker for improved surgical and medical care. Selection bias also may play a role in confounding, with pathologists searching less diligently for all nodes in specimens that show large numbers of lymph nodes grossly involved by tumor. Changes also are occurring within disease trends specifically related to tumor laterality.